Evelyn Partners Group Ltd’s Idexx Laboratories IDXX Stock Holding History

Evelyn Partners Group Ltd’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.9K	Buy	+91	New	+$51K	﹤0.01%	377

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Evelyn Partners Group Ltd's IDXX Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 91 shares worth $47.9K. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings.

715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Evelyn Partners Group Ltd held 91 shares of Idexx Laboratories worth $47.9K as of Q2 2026.
Idexx Laboratories was a new Evelyn Partners Group Ltd position in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #377 holding.
715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.